摘要
合成了一个新型的双核Pt(Ⅳ)配合物{[cis-Pt(NH3)2Cl(OH)2]2(4,4′-methylenedianiline)}(NO3)2(化合物1)及相应的15N标记化合物{[cis-Pt(15NH3)2Cl(OH)2]2(4,4′-methylenedianiline)}(NO3)2(化合物15N-1)。利用1HNMR和ESMS进行了结构表征,化合物15N-1的2D[1H,15N]HSQCNMR发现,该化合物在水溶液中存在同分异构体。2D[1H,15N]HSQCNMR技术跟踪了化合物15N-1与Guanosine-5′-Monophosphate(5′-GMP)和Glutathione(GSH)的反应。结果显示,5′-GMP能在0.5h内将化合物1还原,而GSH在6h以后才能够部分的将化合物1还原。化合物1所表现出来的反应性能将有利于提高其治疗效果和降低毒副作用。
A dinuclear Pt (IV) complex {[cis-Pt (NH3)2Cl (OH)212 (4,4' -methylene-dianiline)} (NO3)2 (compound 1) was synthesized by the oxidation of {[cis-Pt(NH3)2C1]2 (4,4'-methylenedianiline)}(NO3)2, a potent anti-tumor active Pt(ll) complex. The formation of compound 1 was verified by 1H NMR and ES-MS spectroscopy. Compound 1 shows good water solubility. The 15N-labelled compound 1 (15N-1) was synthesized in order to investigate the reactivity of compound 1 towards guanosine-5'-monophosphate(5'-GMP) and glutathione (GSH) by 2D [1H, 15N] HSQC NMR spectroscopy. It was revealed from the 2D [1H, 15N] HSQC NMR spectra that compound 1 could exist in different isomers in aqueous solution. The reactivity of 15N-1 towards 5'-GMP and GSH was followed by 1H NMR and 2D [1H, 15N] HSQC NMR spectroscopy. The Pt(IV) isomers of compound 1 can be fully reduced to Pt(ll) species by 5'- GMP within 0.5 h, while they can only be partly reduced by GSH after 6 h. The reduction products were compared to those of compound 1 and ascorbate incubated for 48 h. The unique reactivity of compound 1 may be desirable for achieving enhanced therapeutic effects and decreased toxic side effects.
出处
《无机化学学报》
SCIE
CAS
CSCD
北大核心
2007年第7期1206-1212,共7页
Chinese Journal of Inorganic Chemistry
基金
国家自然科学基金资助项目(No.20231010)